HEALTH TECHNOLOGY

MetaCell launches innovative Cloud Hosting for life science and healthcare

MetaCell | September 29, 2021

MetaCell, an innovative life science software company specialized in creating cutting-edge research software for major pharma, biotech, and academic institutions, has launched MetaCell Cloud Hosting – a brand new online product providing advanced cloud computing solutions to facilitate research and innovation in life science and healthcare organizations of all sizes.

 

MetaCell specializes in designing custom software services for the pharmaceutical industry, the healthcare sector, and for researchers in academia. In doing so, MetaCell helps its customers overcome challenging information management problems that they have found difficult to navigate with their IT departments and with large service providers like Amazon and Google. MetaCell Cloud Hosting provides scientists, pharmaceutical companies and research institutions with a turnkey online product to host and process their life sciences data and applications.

 

A unique feature provided by MetaCell Cloud Hosting is its customer-tailored capability for biomedical and life science data and software applications that delivers the optimal allocation of cloud resources based on the budget and performance goals of the researchers. This includes affordable storage on trusted servers and access to world-class computing resources, which can be efficiently scaled up to meet the growing need for big data analytics, bioinformatics, digital health, and artificial intelligence. Enabling hosted applications to comply with all major international regulatory frameworks such as GDPR, HIPAA, SOC 2, and relevant ISO standards is another significant value add that MetaCell brings to the market with the release of this new product.

 

"We're thrilled that we are officially launching our MetaCell Cloud Hosting product. From advanced custom software applications to single page websites showing off their work, Cloud Hosting will help researchers avoid the headaches associated with ongoing management of their online software and data holdings."

Stephen Larson, CEO of MetaCell

 

Dr. Rick Gerkin, Associate Research Professor at Arizona State University (ASU), commented: "Besides enabling us to host our research applications and data in a safe cloud infrastructure, MetaCell Cloud Hosting will save us precious time which we'll no longer spend trying to fix technical issues, and instead dedicate it to what we care about most: advancing our research. We've been partnering with MetaCell for a number of years and they have demonstrated their expertise in developing and maintaining our cloud software and databases. We look forward to taking advantage of their new product."

 

About MetaCell

MetaCell is a life science-focused software company composed of scientists and software engineers with deep domain expertise in computational neuroscience, molecular biology, data science, and enterprise-grade online software development. Over the last ten years, MetaCell has established a global presence by partnering with the world's largest pharmaceutical companies including Pfizer and Biogen, leading universities such as Yale University, Princeton University, UCSD, UCL, ASU, SUNY Downstate, and University of Edinburgh, as well as innovative organizations such as CAMH, INCF, and EMBL-EBI.

Spotlight

Patient care organizations are moving forward to connect the academic research arms of their universities to the patient care delivery operations in their clinical organizations. And that is leading both to opportunities and challenges. On the opportunity side, genomic data is now actively being used for rare disease diagnosis; for cancer detection; for the tracking of mutations; and for medication selection for patients.

Spotlight

Patient care organizations are moving forward to connect the academic research arms of their universities to the patient care delivery operations in their clinical organizations. And that is leading both to opportunities and challenges. On the opportunity side, genomic data is now actively being used for rare disease diagnosis; for cancer detection; for the tracking of mutations; and for medication selection for patients.

Related News

HEALTH TECHNOLOGY

MedSec Sets Up a Healthcare Technology Cyber Risk Management Team

MedSec | July 04, 2022

In order to increase its biological and clinical knowledge, MedSec, a premier solutions provider of medical device security, announced it is forming a new Healthcare Technology Cyber Risk Management (HTCRM) team with a roster of seasoned professionals in the sector. The present Chief Product Officer of MedSec and HTCRM authority Phil Englert will take on the position of Advisor for the new team. "MedSec serves stakeholders of all kinds within the medical device eco-system. The establishment of this team allows us to better serve our hospital clients, who are tackling medical device security on a day-to-day basis." Justine Bone, CEO at MedSec "Biomedical and Clinical Engineering teams already have too many things on their plate – and they need leverage. Becoming an extension of their team, augmented by our technology capabilities, we're able to help our customers do things that they would otherwise not be capable of doing with their existing staff. Our clients love the combination of being able to 'speak tech' but also 'understand clinical' to help them further achieve their goals." Andrew Donarumo, Chief Technology Officer at MedSec Englert will continue to assist MedSec in creating security options for hospitals as an advisor. Englert brings to the position extensive understanding of clinical settings and medical technologies. His experience covers more than 30 years of technical and operational leadership in the healthcare and life sciences sector with an emphasis on creating strategic direction, enhancing operations, and undertaking business optimization and transformation efforts that are enabled by data and technology. In addition to governance and operations, vulnerability and patch management, incident response, medical device alerts, and SOC integration, Phil has led the development of medical device security programmes that have made it possible to prioritise strategic initiatives that will have an impact and carry out efficient maintenance and response tasks. In the past, he oversaw the development of strategy and tactics for a $250 million MedTech services business that supported over 130 Acute Care hospitals in 22 states.

Read More

HEALTH TECHNOLOGY

ZetrOZ Systems Highlights the Rise in Health Insurance Denials, Provides Solution

ZetrOZ Systems | May 30, 2022

ZetrOZ Systems, leaders in wearable medical technology and makers of the sam® wearable ultrasound device that heals soft tissue, highlighted the rising health insurance claim denials. The organization is encouraging customers to inform themselves about their healthcare policies and challenge the first denial. Millions of people in the U.S. have experienced the devastating denial of their healthcare claims. According to Change Healthcare, 11% of 102 million medical claims at 1,500 hospitals are denied at first. The rate of denials has gone up by 20% since the year 2016. "Unfortunately, medical policies are driven by insurance company profits and fear of change. Thus, patients are often denied advanced new care when they need to access their healthcare benefits for soft tissue injuries." George K. Lewis, Ph.D. and CEO of ZetrOZ Systems "The first 'no' by an insurance policy can be turned into a 'yes' if you are informed and persistent," Lewis continued. "At ZetrOZ, we encourage patients and providers to not simply give up with the first denial of an insurance claim for therapies like Sustained Acoustic Medicine (sam®). Your insurance should always cover treatments that are proven to be both medically effective and cost-effective." If a denial letter is received, consumers can appeal against the decision. Possible issues include inaccurate paperwork, incorrect billing code, misplaced tax ID or wrongly coding the prescription or procedure. Inspite of sam®’s success, it is usually not covered by the first line of treatment. The reason is often an inadequate understanding of the costs and care by patients, insurers, and insurance providers.

Read More

HEALTH TECHNOLOGY

Noridian Partners and RELI Group Collaborate to Offer Medicare Provider Ownership Verification Services

Noridian Healthcare Solutions | June 28, 2022

In order to evaluate and confirm provider ownership data in Medicare systems, Noridian Healthcare Solutions, LLC (Noridian), a pioneer in creating solutions for federal, state, and commercial health care programs, has joined forces with management consulting firm RELI Group. Noridian is working closely with RELI Group, the prime contractor, as the subcontractor to build a procedure that will guarantee information is correct and complies with Center for Medicare & Medicaid (CMS) approval standards. By preventing and detecting misuse and fraud, the collaboration between Noridian and RELI Group will guarantee that beneficiaries engage with reliable suppliers. “One of Noridian’s main goals is to enable access to health care through our work. However, it’s crucial the care is coming from trusted providers so people can feel confident their health is being put first. We’re honored to work with RELI Group to connect reliable providers with the millions of people who rely on Medicare for access to health care.” Troy Aswege, Senior Vice President of Operations, Noridian All providers participating in the Medicare Part A, Part B, and Durable Medical Equipment (DME) insurance programs are covered by the contract. The primary goals of the contract are to cross-check the Secretary of State (SOS) website with the provider ownership data provided by CMS and to cross-check the results with the Provider Enrollment, Chain, and Ownership System (PECOS). Additionally, with assistance from Noridian, RELI Group will create a standard operating method for every state to successfully authenticate ownership information on the CMS enrollment application. “We place the highest value in supporting CMS in maintaining the dependability of overseeing national and state-based fraud, waste and abuse initiatives across payment programs. Noridian is a valued partner for RELI on this project because they share in our passion for improving healthcare for the nation and they bring proven expertise in Medicare and Medicaid provider enrollment and management.” Scott Bonney, Vice President of Health Information Technology at RELI Grou

Read More